Tech Company Financing Transactions
Haystack Oncology Funding Round
Haystack Oncology, based in Baltimore, raised $56 million in funding from Catalio Capital Management, Alexandria Venture Investments and Bruker.
Transaction Overview
Company Name
Announced On
11/16/2022
Transaction Type
Venture Equity
Amount
$56,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for the continued development and planned 2023 commercialization of its personalized cancer diagnostic test that can detect as few as one mutant molecule in a million DNA molecules.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
301 West 29th St 2004U
Baltimore, MD 21211
USA
Baltimore, MD 21211
USA
Phone
Undisclosed
Website
Email Address
Overview
Haystack Oncology applies the next-generation of ctDNA detection technology to deliver industry-leading sensitivity and specificity for transformative MRD testing
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Edelstein
Chief Technical Officer
Frank Holtrup
Co-Founder
Joshua Cohen
Co-Founder
Nickolas Papadopoulos
Co-Founder
Bert Vogelstein
Browse more venture capital transactions:
Prev: 11/16/2022: Aescape venture capital transaction
Next: 11/16/2022: Cohabs venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs